MEDVi vs Hims for Weight Loss: Which GLP-1 Provider Should You Choose?

The Bottom Line (Read This First)

If you're comparing MEDVi vs Hims, the real question isn't "which is cheaper per month" — it's "how much am I risking if this doesn't work out?"

For most people paying cash for compounded semaglutide, MEDVi is the better starting point. It costs $179 your first month, $299/mo after that, and you're never locked into a contract. You can cancel month-to-month — just give at least 72 hours' notice before your next billing date. If it doesn't work after five months, they'll refund you (minus a 25% consultation fee).

Patients like Melany, who lost 31 pounds on MEDVi's semaglutide program, consistently report that the month-to-month flexibility made them comfortable enough to start.

Hims advertises "$199/mo" for compounded semaglutide injections — but that price requires you to pay six months upfront. That's $1,194 out of your pocket on day one, before you've received your first dose. Hims generally does not refund partially used subscription periods, though refunds may be offered case-by-case at their discretion.

That's the part most comparison sites gloss over. The actual question isn't "which is cheaper per month?" It's "how much am I risking if I'm not sure this is going to work for me?"

Pricing verified directly from medvi.org and hims.com on February 19, 2026.

We've spent months comparing every major GLP-1 telehealth provider — and in this MEDVi vs Hims comparison, we break down the details that actually matter: pricing structure, cancellation risk, pharmacy sourcing, and fine print. MEDVi keeps showing up in ads with that $179 price tag, and Hims is the brand you've probably heard of. Both look legit. Both promise fast approval and medication to your door. But the details between them are more different than you'd think. For the full side-by-side breakdown, see our MEDVi vs Hims comparison table.

MEDVi vs Hims at a Glance: Side-by-Side Comparison

Before we go deeper, here's the full picture in one table. Every number below was verified from official provider websites. Where something is unclear on their end, we've noted it.

Last verified February 19, 2026. Pricing and availability change — always confirm directly with the provider.

Plan lengths and pricing may vary — always verify current options directly on each provider's website before committing.

Illustration for comparison purposes. Actual product packaging and labeling may vary.

What Does MEDVi vs Hims Actually Cost? The Real Numbers

This is where it gets interesting — and where most comparison sites fall short. Advertised monthly prices are borderline meaningless without knowing the commitment structure behind them.

We built this table so you can see what you'll actually spend over time, not what the marketing page wants you to think you'll spend.

Cash You've Actually Paid (Compounded Semaglutide Injectable)

Why this table matters: Hims is cheaper if you stay the full six months — saving about $480 over MEDVi. But the risk profile is completely different. If you quit at month two because the side effects are rough or the medication isn't working, you're out $1,194 with Hims (since prepaid months are generally non-refundable) versus $478 with MEDVi.

If you're not sure you'll last six months — and nobody knows until they try — MEDVi's month-to-month model is the safer bet. You can stop with 72 hours' notice before your next billing date without leaving money on the table.

Think of it this way: MEDVi charges a "flexibility premium" of about $480 over six months. That premium buys you the freedom to walk away any month. Whether that's worth it depends on how certain you are about committing.

Illustration for comparison purposes. Actual product packaging and labeling may vary.

What Happened to the Hims $49 Semaglutide Pill?

In early February 2026, Hims launched a compounded semaglutide pill starting at $49/mo — the cheapest GLP-1 entry point on the market. But within days, it was pulled.

The FDA announced it would take "decisive steps" to restrict companies from mass-marketing non-FDA-approved GLP-1 products. HHS referred Hims to the Department of Justice for investigation. Novo Nordisk filed a patent infringement lawsuit. Hims withdrew the pill on February 7, 2026 .

If you're seeing older articles or ads referencing a $49 Hims semaglutide pill, it is not currently available. Verify directly on hims.com before making any decisions based on that pricing. Hims' injectable semaglutide program ($199/mo with 6-month commitment) continues to operate as of this writing.

The Hidden Costs Checklist

Beyond the monthly medication cost, here's what else you might pay:

MEDVi's pricing is genuinely all-inclusive — medication, consultations, labs when medically necessary, shipping. No surprise line items. That simplicity is worth something when you're budgeting.

Which Provider Is Right for You? (Decision Guide)

Here's the pattern that keeps coming up in reviews and forums:

Choose MEDVi if:

Choose Hims if:

See your doctor instead if:

Your insurance covers Wegovy or Zepbound with a reasonable copay. You have diabetes, heart disease, or complex medical conditions that need in-person monitoring. You specifically want FDA-approved (not compounded) medication and can afford $1,000+/mo or have insurance coverage.

MEDVi Review: What You Actually Get

MEDVi launched in 2023 with a straightforward pitch: all-inclusive GLP-1 pricing, no contracts, fast approvals. No hair loss products, no ED pills, no lifestyle brand play. Just weight loss medication delivered to your door.

How It Works

The process is simple and fast. You fill out an online health assessment — takes about five minutes. A licensed physician (not a chatbot, not a nurse) reviews your information. Most people hear back within 24 hours. If you're approved, your medication ships from a licensed U.S. compounding pharmacy within two business days. It arrives at your door in 5–7 business days. No mandatory video visit required, though you can request a free consultation anytime.

What's Included

Everything. Your monthly payment covers the medication, physician review, personalized treatment plan, metabolic health report, nutrition guidance, 24/7 messaging with your care team, and unlimited telehealth visits. Lab work at partner labs (such as Labcorp) is covered at no extra cost when your provider deems it medically necessary — typically required after month 2–3 as doses increase. Shipping is free. There are no hidden fees.

Medications Available

Compounded semaglutide: $179 first month → $299/mo (injection) or $249 first month → $369/mo (daily oral tablet). Semaglutide is the active ingredient used in FDA-approved Wegovy and Ozempic. In clinical trials of FDA-approved semaglutide (Wegovy), patients lost an average of 14.9% body weight over 68 weeks (NEJM, STEP 1 Trial ). Important: compounded semaglutide products have not been evaluated by the FDA for safety, effectiveness, or quality.

Compounded tirzepatide: Starting at $279 first month — pricing increases with dose ($399–$499/mo). Available as injection or tablet. Tirzepatide is the active ingredient in FDA-approved Zepbound and Mounjaro. It works on two receptors instead of one, and clinical trials of FDA-approved tirzepatide showed up to 22.5% body weight loss — more than semaglutide. Compounded versions have not been FDA-evaluated. If you can afford the premium, it may be worth discussing with your provider.

Brand-name options: MEDVi can also prescribe Ozempic and Wegovy directly (starting at $1,999/mo — you may be able to submit a claim to your insurance for reimbursement). Most patients go with compounded versions for obvious cost reasons.

Senior discount: If you're 65 or older, ask about the $50/mo discount. They don't always advertise it prominently.

The Money-Back Guarantee

This deserves its own mention because almost nobody else offers it. If you follow MEDVi's program for at least five consecutive months — taking the medication as prescribed, completing check-ins — and you haven't lost weight, you're eligible for a refund minus a 25% doctor consultation fee. That's the provider telling you: we stand behind this enough to give your money back if it doesn't work.

Pharmacy and Certification

MEDVi partners with licensed U.S. compounding pharmacies (including Belmar Pharmacy) that follow Good Manufacturing Practices (GMP). MEDVi itself is LegitScript certified, which means an independent third party has verified their compliance and transparency. That certification isn't easy to get and it isn't cheap — the fact that they pursue it signals that they're playing the long game, not the quick-cash game.

Availability

49 states — all except North Dakota. A handful of states (Kansas, Indiana, Mississippi, New Mexico, Oklahoma, West Virginia) require a video visit before prescribing. Alabama and California are injectable only — no oral tablets, per state regulations.

Hims Weight Loss Review: What You Actually Get

Hims (officially Hims & Hers Health, NYSE: HIMS) is one of the biggest names in consumer telehealth. They started with hair loss and ED products, expanded into mental health, and now offer one of the broadest weight loss programs on the market. Where MEDVi is a specialist, Hims is an ecosystem.

How It Works

Similar flow to MEDVi: online health questionnaire, provider review, prescription, delivery. The provider interaction model leans more toward scheduled check-ins and the Hims app experience. You'll have access to a 24/7 care team through messaging, plus regular provider touch-points to adjust your dosage and monitor side effects.

The Medication Menu

This is where Hims really differentiates. They offer more treatment options than most other telehealth weight loss platforms:

Compounded semaglutide injection: From $199/mo with a 6-month plan paid upfront ($1,194 total). This is their direct competitor to MEDVi's core offering.

Compounded semaglutide pill: Hims launched this at $49–$99/mo in early February 2026, but withdrew it within days after FDA enforcement warnings, an HHS referral to the DOJ, and a patent infringement lawsuit from Novo Nordisk. Not currently available — verify directly on hims.com.

Oral medication kits: From $69/mo (10-month plan, upfront). These combine medications like metformin, bupropion, and topiramate — not GLP-1s, but prescription weight loss drugs with clinical evidence behind them. Good option if you want prescription support without injectables.

Brand-name GLP-1s: Wegovy, Ozempic, Zepbound, Mounjaro — available through Hims' platform if prescribed. Pricing varies by insurance and coverage.

Generic liraglutide: From $299/mo (12-month plan, upfront). This is the generic version of Saxenda — a daily injection GLP-1 with a different mechanism than semaglutide.

The Pricing Reality

We need to be straight with you about this, because it's the single most common source of confusion in reviews and forums.

Hims' advertised prices are real — but they're the lowest available rate, which requires the longest commitment paid upfront in full. Here's what that actually looks like:

The "$199/mo" injectable price requires a 6-month plan: you're paying $1,194 at checkout. The "$69/mo" oral kits require a 10-month plan paid upfront. (The "$49 first month" compounded semaglutide pill was withdrawn in February 2026 after FDA action.)

Shorter commitment plans are available, but they cost more per month. And if you cancel early, unused months are generally non-refundable — though Hims may offer refunds case-by-case at their discretion. Subscription changes must be made at least 48 hours before the next payment processes (Hims support ).

This isn't a criticism — it's a business model. Hims passes savings to customers who commit. If you're certain about your timeline, you benefit. If you're uncertain, you're taking on more financial risk.

The App Advantage

Credit where it's due: Hims has the strongest app in the GLP-1 telehealth space. Nutrition tracking, 100+ recipes, behavioral programs, guided start videos, dynamic dose protocols. If you want more than just medication — if you want a structured weight loss program with coaching elements built into an app — Hims genuinely delivers here.

Lab Work

Not automatically included. If your provider determines labs are needed, you'll pay out of pocket — costs vary depending on the lab and your location. This is worth noting because MEDVi covers labs at partner labs at no extra charge when clinically required.

Availability

Hims weight loss is not available in all 50 states. Check eligibility during the Hims intake process — they do not publish a specific state exclusion list.

The Regulatory Situation

In September 2025, the FDA issued Hims & Hers a warning letter regarding claims about their weight loss products. In February 2026, Hims launched and then quickly withdrew a compounded semaglutide pill after the FDA announced it would take "decisive steps" against non-FDA-approved GLP-1 drugs, and HHS referred Hims to the DOJ for investigation. Novo Nordisk filed a patent infringement lawsuit seeking to permanently ban Hims from selling compounded semaglutide.

We're not including this to scare you away from Hims — they're a legitimate, publicly traded company with millions of customers. We're including it because if you're spending your money on GLP-1 medication, you deserve to know the full picture. These are evolving regulatory matters, and Hims continues to operate its injectable semaglutide program while they're resolved.

MEDVi and Hims Patient Reviews: What Real Users Say

We went through hundreds of reviews across ConsumerAffairs, Trustpilot, and provider websites to find patterns — not cherry-picked five-star reviews, but the real themes that keep coming up.

MEDVi Patient Experiences

That review is honest in a way that matters — she admits it wasn't perfect, the side effects were real, and she lost 31 pounds anyway. That's what a genuine experience looks like.

Hims Patient Experiences

What the Reviews Tell You — and What They Don't

Both providers have overwhelmingly positive reviews alongside some negative ones. The negative patterns are similar across both: occasional shipping delays, billing cycle confusion (especially the first month), and customer service wait times during peak hours. This is normal for telehealth platforms handling this volume of patients.

What reviews can't tell you: how your body will respond to the medication, how long your dose titration will take, or whether your appetite suppression will kick in at week two or week six. That's between you and your provider. In clinical trials of FDA-approved semaglutide (Wegovy), patients lost an average of 14.9% body weight — but individual timelines vary, and compounded products have not been FDA-evaluated for the same outcomes.

What's the Catch? Honest Downsides of Both

We're a MEDVi affiliate. We want to be upfront about that and about the fact that MEDVi isn't perfect. No provider is. Here's what you should know.

MEDVi's Biggest Downside

The price jumps after month one. Semaglutide goes from $179 to $299. That's a $120/mo increase, and some patients find it surprising. Over a full year, you're looking at about $3,468 total.

Here's why that's not a dealbreaker:

Brand-name Wegovy costs $1,300–$1,600/mo without insurance. At $299/mo, MEDVi is roughly 80% less — for the same active pharmaceutical ingredient (though as a compounded product, it has not been FDA-evaluated). You're also never locked in. If that price doesn't work for you next month, you just... stop. Give 72 hours' notice before your billing date, and you're done. No calling to argue about a refund. No unreturned $597 sitting in someone else's bank account.

And here's the math that matters: MEDVi patients report losing 1–2 lbs per week on average after the first month. At $299/mo and 6 lbs lost, that's about $50 per pound. At $299/mo and 8 lbs lost, it's $37 per pound. The cost per pound decreases as you progress to higher dosages and see faster results.

Imagine stepping on the scale six months from now, 30+ pounds lighter, wearing clothes you haven't fit into in years. For a lot of people, $299/mo for that transformation isn't a cost — it's the best investment they've ever made in themselves.

Hims' Biggest Downsides

• The upfront commitment. Paying $1,194 on day one before you've received a single dose is a big ask. If GLP-1 isn't right for you — wrong medication, unmanageable side effects, changed financial situation — you've already spent the money, and prepaid months are generally non-refundable.
• Lab work isn't included. If your provider requires baseline labs, that's an additional out-of-pocket expense (costs vary by lab and location). MEDVi includes this.
• No money-back weight loss guarantee. If it doesn't work, there's no refund program. You're relying on the medication and your provider to get it right.
• Regulatory uncertainty. The FDA warning letter, the Novo Nordisk patent infringement lawsuit , the withdrawn oral pill, and the DOJ referral create a layer of uncertainty around Hims' compounded GLP-1 offerings. This doesn't mean Hims will stop operating — they almost certainly won't. But it's worth watching.

What Both Share

Both MEDVi and Hims primarily offer compounded medications. Compounded drugs are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. They are prepared by licensed compounding pharmacies for individual patients based on prescriptions — but the FDA has warned that compounded products should not be marketed as equivalent to FDA-approved medications. This is standard across virtually every telehealth GLP-1 platform at this price point. If you want FDA-approved medication, you're looking at brand-name pricing ($1,000+/mo) or insurance coverage.

Are These Safe? What the FDA Says About Compounded GLP-1s

This section matters more than any pricing table. If the medication isn't safe, nothing else counts.

What "Compounded" Actually Means

Compounded GLP-1 medications are custom-prepared by compounding pharmacies for individual patients. The FDA notes that compounded drugs are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.

Important: For semaglutide specifically, the FDA has noted that some compounded products are made using semaglutide salt forms (such as semaglutide sodium or semaglutide acetate). The FDA states these salts are different active ingredients than the approved products and that it is not aware of a lawful basis for their use in compounding. The FDA has also flagged dosing errors with some compounded semaglutide products.

What to ask your prescriber/pharmacy: (1) Which form of semaglutide is being used — semaglutide base vs. a salt form? (2) How is the dose measured and labeled? These are reasonable questions that any legitimate provider should be willing to answer.

Why Compounding Exists for GLP-1s

Brand-name Wegovy costs $1,300–$1,600/mo without insurance. Most insurance plans don't cover it for weight loss. That leaves millions of people priced out of medication that clinical trials of the FDA-approved versions have proven effective. Compounded versions offer the same active molecule at a fraction of the price — typically $179–$399/mo instead of $1,300+.

The FDA's Position

The FDA's stance has evolved significantly, and most comparison sites get it wrong by oversimplifying. Here's the current picture:

Compounded drugs are legal when prescribed by a licensed provider and filled by a licensed pharmacy for an individual patient based on documented medical necessity. However, the FDA has taken an increasingly firm stance against what it calls "mass compounding" — producing large quantities of compounded GLP-1s marketed as alternatives to brand-name drugs. In February 2026, the FDA announced it would take "decisive steps" to restrict this practice, and the crackdown that followed led to Hims withdrawing its oral pill and facing DOJ referral.

The distinction matters: patient-specific compounding based on individual medical necessity is different from mass-producing compounded drugs and marketing them directly to consumers. The regulatory landscape is actively evolving.

The Shortage Resolution Timeline

FDA removed semaglutide from its drug shortage list on February 21, 2025. During the shortage (2022–2025), compounding pharmacies were allowed to produce copies of FDA-approved semaglutide under a specific exception in federal law. FDA's published compounding policy allowed certain compounding to continue through April 22, 2025 (503A pharmacies) and May 22, 2025 (503B outsourcing facilities), or longer depending on ongoing litigation and court decisions.

After the shortage was marked resolved, the FDA indicated it may take action against compounding that creates "essentially copies" of FDA-approved products (FDA guidance ). Some compounding may still occur under narrow conditions — particularly patient-specific prescriptions with documented medical necessity — but the regulatory landscape is tightening. Ask your provider directly about their pharmacy's compliance status and the legal basis for your prescription.

How to Verify Your Provider Is Legitimate

Before you give any telehealth provider your credit card, check these five things:

1. Do they require a prescription? Any site offering GLP-1 without a prescription is illegal and dangerous. Both MEDVi and Hims require prescriptions from licensed providers.
2. Are their pharmacies licensed? MEDVi uses licensed U.S. compounding pharmacies (including Belmar Pharmacy) that you can verify through your state pharmacy board.
3. Is there LegitScript certification? MEDVi has this. It's an independent verification that the company meets pharmacy standards.
4. Can you reach a real person? Both providers offer messaging and phone support with licensed clinical staff.
5. Are their providers U.S.-licensed? Both MEDVi and Hims use U.S.-licensed physicians and nurse practitioners.

The FDA's BeSafeRx program also provides guidance on identifying safe online pharmacies — look for a U.S. physical address, a phone number, and state pharmacy board licensure.

Common Side Effects to Know About

Both providers prescribe compounded GLP-1 medications, so the expected side effect profile is similar regardless of which you choose:

Most common (and usually temporary): In clinical trials of FDA-approved Wegovy, common adverse reactions included nausea (44%), diarrhea (30%), vomiting (24%), constipation (24%), and abdominal pain (20%). These are dose-related and typically improve within 2–4 weeks as your body adjusts. Starting at a low dose and gradually increasing (called titration) minimizes these effects — and both MEDVi and Hims follow this protocol. Individual results with compounded products may vary.

When to contact your provider: Severe or persistent nausea/vomiting, signs of pancreatitis (severe abdominal pain), changes in vision, or any reaction that concerns you.

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

Who Should NOT Use GLP-1 Medications?

GLP-1 medications are not appropriate for everyone. The following is based on FDA-approved prescribing information for Wegovy (semaglutide) .

Do Not Use (Contraindications per Wegovy Labeling)

Talk to a Licensed Clinician First (Warnings and Cautions)

When to seek urgent medical care: Signs of pancreatitis (severe abdominal pain radiating to the back), signs of an allergic reaction (swelling of face/throat, difficulty breathing), rapid heartbeat, kidney problems (changes in urination), or gallbladder issues (upper stomach pain, fever, jaundice).

Both MEDVi and Hims screen for these conditions during the health assessment process. But if you have any of the above, disclose them to your provider — even if the online form doesn't specifically ask.

This section is based on FDA-approved prescribing information and is not a substitute for your provider's medical judgment.

Is MEDVi Legit? How to Verify in 5 Minutes

This question gets searched thousands of times per month, so let me answer it directly.

Yes. MEDVi is a legitimate telehealth company. Here's the evidence:

• LegitScript Certified. LegitScript is an independent certification body that verifies online healthcare companies for regulatory compliance, pharmacy standards, and business practices. Earning this certification requires real documentation and ongoing compliance monitoring.
• Licensed U.S. pharmacy partners. MEDVi uses licensed U.S. compounding pharmacies (including Belmar Pharmacy). You can check their licensure through your state pharmacy board.
• Real licensed providers. Every MEDVi prescription is reviewed and signed by a U.S.-licensed physician or nurse practitioner.
• Thousands of verified patient reviews. Nearly 10,000 reviews on Trustpilot (4.5-star rating), plus extensive reviews on ConsumerAffairs with verified purchase details.
• Money-back guarantee. Scam companies don't offer refund programs for non-results. MEDVi's five-month guarantee signals legitimate confidence in their product.

MEDVi's Trustpilot rating is strong at 4.5 stars, though ConsumerAffairs reviews skew lower — with most complaints focused on billing timing and cancellation friction, issues we address in detail in our cancellation section below.

Can you order MEDVi online? Yes — it's an entirely online telehealth platform. The process is: online health assessment → provider review → prescription → medication shipped to your door.

MEDVi prescriptions in 24 hours? That's realistic for most patients. The online assessment takes about five minutes, and most patients receive their provider's decision within 24 hours. Actual medication delivery takes an additional 5–7 business days after approval.

The "30-day guarantee"? MEDVi's guarantee is actually a five-month program — if you haven't lost weight after following the program for five consecutive months, you're eligible for a refund minus a 25% doctor consultation fee. It's not a 30-day trial. Read the actual terms before signing up so expectations are set correctly.

Refunds, Cancellations, and What Happens If You Want to Stop

This is one of the biggest anxiety points for people considering GLP-1 telehealth. Nobody wants to feel trapped. Here's exactly how each provider handles it.

MEDVi Cancellation

MEDVi is month-to-month with no contract. To cancel, you need to submit your request at least 72 hours before your next billing date to avoid the next charge. If your medication has already been ordered to the pharmacy for that billing cycle, that cycle is non-refundable — per federal law, prescribed medications cannot be returned once dispensed. Refunds apply only to the most recent billing cycle.

Pro tip: Set a calendar reminder 4–5 days before your billing date. MEDVi's billing starts from your signup date, not when you receive your medication. This is a common point of confusion in patient reviews. Know your billing date, and you'll never be surprised.

Hims Cancellation

You can cancel your Hims subscription, but subscription changes must be made at least 48 hours before the next payment processes (Hims support ). Prepaid months are generally non-refundable, though Hims may offer refunds case-by-case at their discretion. If you paid $1,194 for a 6-month plan and cancel at month 3, you've already paid for the remaining months — and getting that back is not guaranteed. Read Hims' current refund terms before committing to any prepaid plan.

This is the trade-off for Hims' lower per-month pricing. You're saving money per month, but you're paying for the full commitment regardless of whether you use it.

Illustration for comparison purposes. Actual product packaging and labeling may vary.

The "Don't Get Burned" Playbook

Whichever provider you choose:

1. Screenshot your order confirmation and save the billing date
2. Set a recurring calendar reminder 5 days before billing
3. Save the customer support email/chat link somewhere easy to find
4. If you want to cancel, don't wait until billing day — do it at least a week before

Billing friction exists across the entire telehealth industry. It's not unique to MEDVi or Hims. The difference is how much financial exposure you have if you need to stop — and that's where MEDVi's month-to-month model (cancel 72+ hours before billing) provides a clear advantage over Hims' prepaid commitment structure.

Shipping, Packaging, and What "Fast" Actually Means

Delivery anxiety is real. You've made the decision, entered your payment info, and now you're refreshing your email every two hours waiting for a tracking number. Here's what to actually expect.

MEDVi Shipping Timeline

Once your provider approves your prescription — which typically happens within 24 hours of completing the health assessment — your medication is sent to the pharmacy for compounding and fulfillment. Most patients see shipment within 2 business days of approval. Delivery takes 5–7 business days depending on your location.

Total time from signup to first dose: roughly 7–10 days for most people. Some patients report receiving their medication in as few as 5 days.

Medications arrive in discreet packaging with no indication of what's inside. Injectables should arrive properly refrigerated — if your package feels warm or the cold pack is completely melted, contact MEDVi support before using the medication.

Hims Shipping Timeline

Similar process: assessment, provider review, prescription, shipment. Hims ships from their own network of affiliated pharmacies. Delivery is free with discreet packaging. Exact timelines vary by your location and which medication you're prescribed, but most patients report a comparable 7–10 day window from signup to delivery.

What to Do If Your Shipment Is Late

It happens. Pharmacies get backed up, carriers have delays, weather happens. If your medication hasn't arrived within 10 business days:

1. Check your tracking number (both providers send one via email)
2. Contact the provider's support team — MEDVi offers 24/7 chat, Hims has messaging support
3. Ask about a replacement shipment if the package appears lost
4. Don't wait until you're completely out of medication to reorder

One review on ConsumerAffairs specifically mentioned a FedEx lost package situation with MEDVi. It's worth noting that shipping issues aren't a provider problem — they're a carrier problem. But how the provider responds matters. Document everything and escalate if needed.

What to Expect Your First Month on GLP-1

Whether you choose MEDVi or Hims, here's what the first 30 days typically look like — because knowing what's normal keeps you from panicking and quitting too early.

Week 1: Getting Started

Your provider will start you on the lowest dose. For semaglutide, that's typically 0.25mg per week. At this dose, most people feel... not much. Maybe slightly less hungry. Maybe a bit of mild nausea after eating. Don't be discouraged if you don't feel dramatic appetite suppression right away — that's by design. The low starting dose lets your body adjust gradually.

If you're doing injections, the first self-injection is the part most people dread the most and find the easiest in hindsight. The needle is small. MEDVi and Hims both provide instructions. Most patients do it in the thigh or abdomen. It takes about 30 seconds.

Weeks 2–4: Side Effects Peak (Then Fade)

This is when side effects are most noticeable for most people. Nausea is the big one — it usually shows up 1–3 days after injection and fades before the next dose. Constipation is the second most common complaint. Both are manageable:

For nausea: eat smaller meals, avoid greasy or heavy food, stay hydrated, eat slowly. Most patients find that nausea resolves within 2–3 weeks as their body adapts.

For constipation: increase fiber intake, drink more water, consider a stool softener or magnesium supplement. Melany from ConsumerAffairs mentioned this was her worst side effect — and she researched solutions, stuck with the program, and lost 31 pounds.

Week 4 and Beyond: Results Start

Most patients notice real appetite changes by the end of the first month, especially as their provider titrates the dose upward. The medication doesn't make you unable to eat — it reduces the obsessive food noise. The constant "what should I eat next" mental loop gets quieter. That's when behavior change becomes easier, because you're not fighting your own biology anymore.

Typical weight loss in the first month: 4–8 pounds, though this varies widely. Some people lose more on semaglutide, some lose more on tirzepatide. Don't compare your week-3 results to someone else's month-6 results on TikTok.

The Mental Shift Nobody Talks About

The thing nobody prepares you for is how different it feels to not be controlled by food. Patients describe it as "freedom" and "quiet" — the constant background noise of hunger and cravings just... dims. That psychological relief is often more powerful than the number on the scale.

This is why the month-to-month flexibility of MEDVi matters so much for first-timers. You need time to see if your body responds well. You need 30–60 days before making a judgment call. MEDVi gives you that window without financial pressure. If month two feels good, you continue. If it doesn't, you stop — and you've only spent $478 instead of $1,194.

Semaglutide vs Tirzepatide: Which Medication Should You Ask About?

Both MEDVi and Hims offer semaglutide. But MEDVi also offers tirzepatide at a transparent cash-pay price, and this is worth understanding before you sign up.

Semaglutide (the active ingredient in FDA-approved Wegovy/Ozempic) works on one receptor — GLP-1. In clinical trials of the FDA-approved version, patients lost an average of 14.9% body weight over 68 weeks. It's the most studied and most widely used GLP-1 for weight loss.

Tirzepatide (the active ingredient in FDA-approved Zepbound/Mounjaro) works on two receptors — GLP-1 and GIP. In clinical trials of the FDA-approved version, patients lost up to 22.5% body weight, with greater reductions in waist circumference compared to semaglutide. It's newer but the clinical data is compelling.

Important: These trial results are for FDA-approved products. Compounded versions have not been evaluated by the FDA for the same outcomes.

Through MEDVi, tirzepatide starts at $279 first month with ongoing pricing from $399–$499/mo depending on dose — more than semaglutide. That premium buys you a potentially more effective medication, especially if you have more aggressive weight loss goals or if semaglutide alone isn't producing sufficient results.

Hims offers brand-name Zepbound and Mounjaro (at insurance-dependent pricing), but doesn't currently offer compounded tirzepatide at a transparent cash-pay price the way MEDVi does.

If you're not sure which to start with, here's a simple framework: start with semaglutide (it's cheaper and well-studied), give it 3–4 months, and if results plateau, talk to your MEDVi provider about switching to tirzepatide. The ability to switch medications without changing providers is one of MEDVi's underrated advantages.

If You Have Insurance, Should You Skip Both?

Honest answer: maybe.

If your insurance covers brand-name Wegovy or Zepbound with a copay under $100/mo, going through your primary care doctor or an endocrinologist is almost certainly the better financial move. You'd be getting FDA-approved, brand-name medication at a fraction of what either MEDVi or Hims charges for compounded versions.

The reality, though, is that most insurance plans don't cover GLP-1 medications for weight loss — or they require extensive prior authorization, BMI thresholds, documented failure of other weight loss methods, and months of waiting. Even with insurance, your copay might be $300–$500/mo for Wegovy.

If you have good insurance: Call your plan, ask specifically about GLP-1 coverage for weight loss (not diabetes), and get the copay amount in writing before making any decisions.

If your insurance doesn't cover it (or barely covers it): Cash-pay through MEDVi or Hims is the path. Both accept HSA/FSA, which lets you use pre-tax dollars. MEDVi also notes that brand-name Ozempic/Wegovy prescriptions may be submitted to your insurance for potential reimbursement.

Also worth noting: Novo Nordisk launched an FDA-approved Wegovy pill in January 2026, with a self-pay starting price around $149/month for the lowest dose. If you specifically want an FDA-approved oral option, this may be worth discussing with your doctor — though higher doses will cost significantly more.

Other Providers People Compare (So You Don't Have to Search Again)

If you're still shopping — or if you're looking at this page after already researching other options — here's how MEDVi and Hims stack up against the other names you'll see.

MEDVi vs Ro: Ro's Body Program is one of the most established telehealth weight loss platforms. They offer both compounded semaglutide and brand-name options (Wegovy, Zepbound) with weekly coaching. The catch: Ro charges a $149/mo membership fee on top of medication costs, and their combined pricing can run significantly higher than MEDVi's all-inclusive rate. Ro is the best choice if you have quality insurance and want brand-name medication with hands-on coaching support. For cash-pay patients who want the simplest and most affordable path, MEDVi wins. See our full MEDVi vs Ro comparison.

MEDVi vs Remedy Meds: Remedy Meds operates on almost the exact same model as MEDVi — transparent all-inclusive cash-pay pricing, no contracts, no membership fees. Their compounded semaglutide is $299/mo (no intro discount like MEDVi's $179 first month). Where Remedy differentiates: they offer both injectable and oral compounded GLP-1s at the same price. If oral tablets at a comparable price to MEDVi matter to you, Remedy is worth a look. But MEDVi's lower first-month price and money-back guarantee give it an edge for first-time patients. See our full MEDVi vs Remedy Meds comparison.

Hims vs Henry Meds: Henry Meds shows up frequently in Reddit discussions about GLP-1 providers. They offer bundled telehealth + compounded semaglutide programs with options advertised as low as $197/month — straightforward, but more expensive than MEDVi's $179 first month. They don't offer a money-back guarantee, 24/7 provider access, or the breadth of medication options that Hims provides. For the price, MEDVi and Hims both offer more value.

Hims vs Found: Found emphasizes behavioral coaching, community support, and habit-building alongside medication. Plans start at $39/mo, but that doesn't include medication. The medication is prescribed separately and costs vary. If you want a structured behavioral program with community elements and you're less price-sensitive, Found is interesting. But for pure GLP-1 access at the best price, Hims and MEDVi are more direct paths.

"Best GLP-1 provider Reddit": Reddit threads are useful for unfiltered patient experiences, but take specific provider recommendations with a grain of salt. Many posts are affiliate-driven or based on outdated pricing. The most reliable Reddit advice tends to be about the medications themselves (semaglutide vs tirzepatide, dosing experiences, side effect management) rather than specific providers. For provider-level comparisons, you need verified pricing — which is what this page provides.

How We Compared MEDVi and Hims (Our Methodology)

I believe you should know exactly how we built this comparison and where our biases might exist.

What we compared: We evaluated MEDVi and Hims across eight categories — pricing transparency, medication options, contract terms, cancellation flexibility, clinical support, pharmacy sourcing, patient reviews, and regulatory compliance.

How we verified pricing: Every price on this page was checked directly from each provider's official website (medvi.org , hims.com ). We record the verification date and update within one week of any pricing change. The last full verification was February 19, 2026.

How we sourced reviews: Patient testimonials were pulled from ConsumerAffairs, Trustpilot, and each provider's published testimonials. We did not fabricate, modify, or compensate any reviewer. We selected reviews that represent common themes — not just five-star outliers.

Our affiliate relationship: We are an affiliate of MEDVi. We may earn a commission if you sign up through our links. This does not affect our comparison methodology, our pricing verification process, or our willingness to recommend Hims when it's the better fit for certain profiles. We've recommended Hims multiple times in this guide for specific situations where it genuinely wins.

What we don't do: We do not accept payment from any provider to influence rankings. We do not fabricate reviews. We do not suppress legitimate negative information about our affiliate partner.

Update schedule: This page is reviewed monthly and fully re-verified quarterly. If a provider changes pricing or policies, we update within seven business days.

Editorial Standards

• We verify every price claim directly from official provider websites (medvi.org, hims.com) — never from third-party aggregators
• Clinical claims cite specific published trials with journal names and links
• Patient reviews are sourced from verified review platforms (ConsumerAffairs, Trustpilot) — never fabricated
• We re-verify all pricing monthly and perform a full audit quarterly
• Our affiliate relationship with MEDVi is disclosed at the top of this page

Common Questions Before You Sign Up

MEDVi vs Hims FAQ

The Bottom Line: MEDVi vs Hims

Both MEDVi and Hims are legitimate providers helping real people lose real weight with GLP-1 medications. We've verified their pricing, read hundreds of patient reviews, and dug into their policies. They both work. The right choice comes down to what matters most to you.

Choose MEDVi if you want transparent, all-inclusive pricing with no upfront commitment and a money-back guarantee backing the whole thing. It's the lower-risk entry point — especially if this is your first time trying GLP-1 medication. You'll pay a bit more per month than Hims' long-term rates, but you'll sleep better knowing you can walk away any time without leaving money behind. For most people who are excited but cautious, ready but wanting to test the waters — MEDVi is where we'd start.

Choose Hims if you want the broadest medication menu, a polished app experience, and you're confident enough in your commitment to pay upfront for six months. If you value having a household brand name behind your healthcare, that credibility has real value.

Either way, you're taking a step that millions of people wish they had the courage to take. The science behind GLP-1 medications is strong. In clinical trials of FDA-approved semaglutide (Wegovy), patients lost nearly 15% of their body weight on average — and real patients using both MEDVi and Hims report meaningful results in their own lives. Individual results vary, and compounded products have not been FDA-evaluated.

Six months from now, you could be 25–35 pounds lighter. Your energy could be different. The way you feel getting dressed in the morning could be different. That's not marketing — that's what the clinical data shows and what thousands of patients report.

You've done the research. You've read the fine print. You know the prices, the risks, and the trade-offs. The only thing left is the decision — and you already know which one feels right.

The only wrong choice is staying stuck because you couldn't decide between two good options. Pick one. Start. Adjust later if you need to. The hardest part isn't the medication — it's the moment right before you click "start."

Sources

• FDA — Action Against Non-FDA-Approved GLP-1 Drugs (Feb 2026)
• FDA — Compounding Policies as GLP-1 Supply Stabilizes
• NEJM STEP 1 Trial
• MEDVi.org (pricing, refund policy)
• Hims.com (pricing, terms)
• Hims Refund Policy
• BioPharma Dive — Hims Pill Withdrawn
• CNBC — Novo Nordisk Sues Hims
• ConsumerAffairs — MEDVi Reviews
• Trustpilot — MEDVi Reviews
• LegitScript.com
• FDA BeSafeRx
• FDA Wegovy Prescribing Information
• FDA — Concerns About Unapproved GLP-1 Drugs
• FDA — Dosing Errors in Compounded Semaglutide
• Healthline — Hims Wegovy Pill and Lawsuit Coverage
• Henry Meds Semaglutide Programs
• Ro Weight Loss Pricing

This page was last updated February 2026. Pricing and policies verified from official provider websites. For questions about this comparison, contact our research team. For medical questions, consult a licensed healthcare provider.